“The Past, Present, and Future of STK11 Mutations In Non-Small Cell Lung Carcinoma”
At the conclusion of this activity, the participant will be able to:
1. Discuss the impacts of advancing molecular diagnostics on non-small cell lung carcinoma
2. Identify the role of STK11 gene mutations in the setting of non-small cell lung carcinoma
3. Assess the role of targeted therapies for non-small cell lung carcinoma as our understanding of mutational profiles expands